GEA
EDIT icon

Glen Eagle Advisors’s Editas Medicine EDIT Stock Holding History

Glen Eagle Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-40
Closed -$1.64K – 976
2021
Q3 		$1.64K Buy
+40
New +$2.19K ﹤0.01% 947
2020
Q3 		– Sell
-75
Closed -$2.22K – 927
2020
Q2 		$2.22K Hold
75
– – ﹤0.01% 751
2020
Q1 		$1.49K Hold
75
– – ﹤0.01% 728
2019
Q4 		$2.22K Hold
75
– – ﹤0.01% 770
2019
Q3 		$1.71K Hold
75
– – ﹤0.01% 720
2019
Q2 		$1.86K Hold
75
– – ﹤0.01% 703
2019
Q1 		$1.83K Hold
75
– – ﹤0.01% 658
2018
Q4 		$1.71K Hold
75
– – ﹤0.01% 640
2018
Q3 		$2.39K Buy
+75
New +$2.42K ﹤0.01% 619

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Glen Eagle Advisors's EDIT Position: Q4 2021 in Review

Glen Eagle Advisors sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 40 shares — an estimated $1.64K sold.

Glen Eagle Advisors first reported a position in EDIT in Q3 2018 and held it in 9 quarters. The position peaked at $2.39K in Q3 2018. 305 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.

  • Glen Eagle Advisors reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
  • Glen Eagle Advisors sold 40 Editas Medicine shares in Q4 2021, an estimated $1.64K.
  • Glen Eagle Advisors first reported a position in Editas Medicine in Q3 2018 and held it in 9 quarters.
  • Glen Eagle Advisors's Editas Medicine position peaked at $2.39K in Q3 2018.
  • 305 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.

Based on Glen Eagle Advisors's 13F filing for Q4 2021, filed 13 Aug 2024.